Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013

Affiliations

• ¹ Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. Electronic address: Lars.Wallentin@ucr.uu.se.
• ² Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
• ³ Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
• ⁴ Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
• ⁵ AstraZeneca Research and Development, Mölndal, Sweden.
• ⁶ Medical Department, Hospital Unit West, Herning/Holstbro, Denmark.
• ⁷ Medizinishe Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany.
• ⁸ Department of Medicine, Stanford University, Stanford, CA, USA.
• ⁹ Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom.
• ¹⁰ INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France.